The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
dMMR/MSI tumour occurrence during follow-up of patients with Lynch syndrome treated with immune checkpoint inhibitors for a metastatic digestive cancer between 2015 and 2024: A retrospective monocentric cohort.
 
Anna Pellat
Consulting or Advisory Role - Merck; Servier
Travel, Accommodations, Expenses - Merck; Servier
 
Camille Loisel
No Relationships to Disclose
 
Antoine Dardenne
No Relationships to Disclose
 
Thierry Andre
Honoraria - Bristol-Myers Squibb; Merck; Merck Serono; Sanofi; Seagen; SERVIER
Consulting or Advisory Role - Abbvie; Aptitude Health; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; MSD Oncology; Nimbus Therapeutics; Nordic Bioscience; Pfizer; Seagen; SERVIER; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Takeda
Other Relationship - Inspirna
(OPTIONAL) Uncompensated Relationships - Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group; ARCAD Foundation; ARCAD Foundation